KatieB 344 Report post Posted November 15, 2017 Reposting this opportunity that came across my desk: Quote Flince Research + Design, an independent healthcare research company located in the U.S., is conducting a project to understand issues and concerns that face ALK+ lung cancer patients as they make treatment decisions. The goal of the project is to support the development of patient programs and services. Your participation can help to enhance awareness and education around ALK+ lung cancer for those who live with it, and for the health professionals who treat it. The research consists of a one-hour discussion by phone and a three-day diary. The project is open to all U.S. residents who live with ALK+ lung cancer who have been or are currently on an ALK inhibitor. Research will be completely confidential. In appreciation of your time and valuable contribution, you will receive an honorarium of $350. For more information about participation, please contact: Jason Turner, Field Director, Flince Research & Design, 773-383-9090, [email protected] Quote Share this post Link to post Share on other sites
